Editas Medicine (EDIT) & BAVARIAN NORDIC/S (BVNRY) Critical Analysis
Editas Medicine ( NASDAQ:EDIT ) and BAVARIAN NORDIC/S ( OTCMKTS:BVNRY ) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, institutional ownership, dividends, profitability and earnings. Risk & Volatility Editas Medicine has a beta of 3.37, indicating that its share price is 237% more volatile than the S&P 500. Comparatively, BAVARIAN NORDIC/S has a beta of 0.68, indicating that its share price is 32% less volatile than the S&P 500. Valuation & Earnings This table compares Editas Medicine and BAVARIAN NORDIC/S’s gross revenue, earnings per share (EPS) and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Editas Medicine $13.73 million 84.70 -$120.32 million ($2.98) -8.18 BAVARIAN NORDIC/S $208.06 million 3.86 $27.54 million $0.29 28.59 BAVARIAN NORDIC/S has higher rev...